iTeos Therapeutics price target lowered to $19 from $31 at Wells …

ITeos Therapeutics Price Target Lowered To $19 From $31 At Wells …

1 week from now

Dec 20, 2024  · Wells Fargo lowered the firm’s price target on iTeos Therapeutics (ITOS) to $19 from $31 and keeps an Overweight rating on the shares. The firm adjusted price targets in the Smid-cap ...

yahoo.com

ITeos Therapeutics (NASDAQ:ITOS) Price Target Lowered To $19.00 …

1 week from now

Dec 19, 2024  · Wells Fargo & Company cut their price objective on shares of iTeos Therapeutics from $31.00 to $19.00 and set an "overweight" rating for the company in a research report on …

marketbeat.com

ITeos Therapeutics, Inc. (ITOS) - Yahoo Finance

1 week from now

Wells Fargo lowered the firm’s price target on iTeos Therapeutics (ITOS) to $19 from $31 and keeps an Overweight rating on the shares. The firm adjusted price targets in the Smid-cap ...

yahoo.com

ITeos Therapeutics (ITOS) Stock Forecast And Price Target 2025

1 week from now

Jan 8, 2025  · According to the 4 analysts' twelve-month price targets for iTeos Therapeutics, the average price target is $22. ... 12/19/2024: Wells Fargo & Company. 3 of 5 stars: E. Fortea …

marketbeat.com

ITeos Therapeutics Stock Price | ITOS Stock Quote, News, And …

1 week from now

6 days ago  · The latest iTeos Therapeutics stock prices, stock quotes, news, and ITOS history to help you invest and trade smarter. ... iTeos Therapeutics price target lowered to $19 from $31 …

businessinsider.com

ITeos Therapeutics (ITOS) News Today - MarketBeat

1 week from now

Jan 3, 2025  · Wells Fargo & Company cut their price objective on shares of iTeos Therapeutics from $31.00 to $19.00 and set an "overweight" rating for the company in a research report on …

marketbeat.com

ITeos Therapeutics Outlines Business Updates, Strategies For 2025

1 week from now

Jan 10, 2025  · iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo; iTeos Therapeutics price target lowered to $21 from $46 at H.C. Wainwright; iTeos Therapeutics …

businessinsider.com

ITeos Therapeutics Reports Q3 2024 Financial Results

1 week from now

Nov 13, 2024  · iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo. TipRanks 20d. ... TipRanks 26d. iTeos Therapeutics price target lowered to $21 from $46 at H.C. …

businessinsider.com

ITOS - ITeos Therapeutics Inc Stock Price And Quote - FINVIZ.com

1 week from now

iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo (TipRanks) Dec-13-24 01:25PM ... Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains …

finviz.com

Wells Fargo & Company Issues Pessimistic Forecast For ITeos ...

1 week from now

Dec 21, 2024  · iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price objective reduced by equities research analysts at Wells Fargo & Company from $31.00 to $19.00 in a …

etfdailynews.com

ITeos Therapeutics (NASDAQ:ITOS) Given New $19.00 Price Target …

1 week from now

Dec 19, 2024  · iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $31.00 to $19.00 in a …

techdows.com

ITeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed

1 week from now

6 days ago  · Wells Fargo & Company dropped their price target on shares of iTeos Therapeutics from $31.00 to $19.00 and set an "overweight" rating on the stock in a research note on …

marketbeat.com

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy

1 week from now

WellsFargo analyst Eva Fortea Verdejo maintains $ITeos Therapeutics(ITOS.US)$ with a buy rating, and adjusts the target price from $31 to $19.According to TipRanks ...

moomoo.com

ITeos Therapeutics, Inc. (ITOS) - Yahoo Finance

1 week from now

Interactive Chart for iTeos Therapeutics, Inc. (ITOS), analyze all the data with a huge range of indicators. ... iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo.

yahoo.com

ITeos Therapeutics (NASDAQ:ITOS) Earns "Buy" Rating From

1 week from now

1 day ago  · Wells Fargo & Company decreased their price target on iTeos Therapeutics from $31.00 to $19.00 and set an "overweight" rating on the stock in a research note on Thursday, …

marketbeat.com

ITeos Therapeutics (NASDAQ:ITOS) Earns Outperform Rating From …

1 week from now

4 days ago  · Wells Fargo & Company lowered their target price on iTeos Therapeutics from $31.00 to $19.00 and set an “overweight” rating for the company in a research note on …

etfdailynews.com

Wells Fargo Maintains Overweight On ITeos Therapeutics, Lowers …

1 week from now

Dec 19, 2024  · Wells Fargo analyst Eva Fortea Verdejo maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from $31 to $19.

sahmcapital.com